Jason
jason10033.bsky.social
Jason
@jason10033.bsky.social
Med-Peds ID.
Research on Improving the Sexual Health Cascade of Care (HIV, HIV Prevention, STI, and Mpox)
Reposted by Jason
Congratulations to Dr. Jason Zucker @jason10033.bsky.social who received the Dr. Linda Laubenstein #HIV Clinical Excellence Award from the New York State Department of Health AIDS Institute!!!
December 12, 2024 at 5:14 PM
Reposted by Jason
Turns out the antiviral TPOXX (tecovirimat) doesn't work for mild/moderate Clade II #mpox ( #monkeypox) either, as previously shown for Clade I. Many treated people reported improvement, but symptoms typically resolve anyway -- that's why we need controlled trials.

www.niaid.nih.gov/news-events/...
NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain
Tecovirimat was safe but did not reduce the time to lesion resolution or reduce pain among adults with mild to moderate clade II mpox and a low risk of severe disease in an international study.
www.niaid.nih.gov
December 10, 2024 at 8:23 PM
Reposted by Jason
Greetings #IDSky! Thrilled to welcome Melissa, Jeff, and Ann to our ID fellowship program!!!! ❤️‍🌟
December 4, 2024 at 8:54 PM
November 20, 2024 at 2:00 PM
Reposted by Jason
Mpox is a viral infection transmitted primarily through close skin-to-skin contact. This review describes the epidemiology, transmission, clinical presentation, assessment and diagnosis, prognosis, management and treatment, and prevention of mpox.

https://ja.ma/3Oiaiu1
November 19, 2024 at 5:00 PM